<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - SULFASALAZINE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>SULFASALAZINE</h1>

        <p><a href="../drugClass/PHP34554.html">AMINOSALICYLATES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Treatment of acute attack of mild to moderate and severe ulcerative colitis</span>,
                <span class="indication">Active Crohn's disease</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1&#8211;2 g 4 times a day until remission occurs, corticosteroids may also be given, if necessary.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                0.5&#8211;1 g twice daily, administered alone or in conjunction with oral therapy, morning and night after a bowel movement.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Maintenance of remission of mild to moderate and severe ulcerative colitis</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg 4 times a day.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                0.5&#8211;1 g twice daily, administered alone or in conjunction with oral therapy, morning and night after a bowel movement.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Active rheumatoid arthritis (administered on expert advice)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 500 mg daily, increased in steps of 500 mg every 1 week, increased to 2&#8211;3 g daily in divided doses, enteric coated tablets to be administered.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Theoretical risk of neonatal haemolysis in third trimester; adequate folate supplements should be given to mother.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Use with caution.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

        
            <section class="generalInformation">
              <p>Risk of toxicity, including crystalluria, in moderate impairment&#8212;ensure high fluid intake.</p><p>Avoid in severe impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>Child under 2 years of age</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Blood disorders, cough, dizziness, fever, Heinz body anaemia, insomnia, megaloblastic anaemia, proteinuria, pruritus, stomatitis, taste disturbances, tinnitus,
              </p>
              <p>
                <strong>uncommon:</strong> Alopecia, convulsions, depression, dyspnoea, vasculitis,
              </p>
              <p>
                <strong>notKnown:</strong> Anaphylaxis, aseptic meningitis, ataxia, crystalluria, disturbances of smell, epidermal necrolysis, exfoliative dermatitis, gastro-intestinal intolerance, hallucinations, hypersensitivity reactions, leucopenia (especially in patients with rheumatoid arthritis), loss of appetite, neutropenia (especially in patients with rheumatoid arthritis), oligospermia, parotitis, photosensitivity, rashes, serum sickness, some soft contact lenses may be stained, thrombocytopenia (especially in patients with rheumatoid arthritis), yellow-orange discoloration of other body fluids, yellow-orange discoloration of skin, yellow-orange discoloration of urine,
              </p>
        
        
            <section class="advice">
                <h3>Gastro-intestinal side effects</h3>
              <p>Upper gastro-intestinal side-effects common over 4&#8239;g daily.</p>
            </section>
            <section class="advice">
                <h3>Blood disorders</h3>
              <p>Haematological abnormalities occur usually in the first 3 to 6 months of treatment and are reversible on cessation of treatment.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
                <h3>Contact lenses</h3>
              <p>Some soft contact lenses may be stained.</p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            <xref format="dita" href="#PHP78608" type="bookmark" namespace="/treatment-summaries/acute-porphyrias">Acute porphyrias</xref>
          </li>
          <li>
            G6PD deficiency
          </li>
          <li>
            history of allergy
          </li>
          <li>
            history of asthma
          </li>
          <li>
            maintain adequate fluid intake
          </li>
          <li>
            risk of haematological toxicity
          </li>
          <li>
            risk of hepatic toxicity
          </li>
          <li>
            slow acetylator status
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
                <h3>Blood disorders</h3>
              <p>Close monitoring of full blood counts (including differential white cell count and platelet count) is necessary initially, and at monthly intervals during the first 3 months.</p>
            </section>
            <section class="patientParameters">
                <h3>Renal function</h3>
              <p>Although the manufacturer recommends renal function tests in rheumatic diseases, evidence of practical value is unsatisfactory.</p>
            </section>
            <section class="patientParameters">
                <h3>Liver function</h3>
              <p> Liver function tests should be performed at monthly intervals for first 3 months.</p>
            </section>
      </section>











      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of SULFASALAZINE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            oral suspension,

            <div id="PHP76560"><a href="../medicinalForm/PHP76560.html" data-target="#PHP76560" data-action="load">Tablet</a></div>
            <div id="PHP76635"><a href="../medicinalForm/PHP76635.html" data-target="#PHP76635" data-action="load">Gastro-resistant tablet</a></div>
            <div id="PHP76870"><a href="../medicinalForm/PHP76870.html" data-target="#PHP76870" data-action="load">Oral suspension</a></div>
            <div id="PHP76787"><a href="../medicinalForm/PHP76787.html" data-target="#PHP76787" data-action="load">Suppository</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
